Non-mutagenic impurities – Recent industry experience of using dose durational limits in drug development
Author:
Andreanne Lortie,Elizabeth A. Martin,Kate Arnot
Publication:
Regulatory Toxicology and Pharmacology
© 2024 The Authors. Published by Elsevier Inc.